登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688317 证券简称：之江生物公告编号：2025-065 上海之江生物科技股份有限公司 关于2025年第三次以集中竞价交易方式回购公司股份的 进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次回购股份符合相关法律法规的规定及公司的回购股份方案。 三、其他事项 公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第7号一一回购股 份》等相关规定，在回购期限内根据市场情况择机做出回购决策并予以实施，同时根据回购股份事项进 展情况及时履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 ■ 一、回购股份的基本情况 2025年10月15日，上海之江生物科技股份有限公司（以下简称"公司"）召开第五届董事会第十六次会 议，审议通过了《关于以集中竞价交易方式回购公司股份方案的议案》，同意公司以自有资金和股票回 购专项贷款资金通过集中竞价交易方式回购公司部分股份，回购的股份拟用于员工持股计划或股权激 励，回购股份价格不超过人民 ...

Core Insights - The Life Valley (International) Bioengineering Innovation Center has been launched, focusing on the integration of life sciences and future industry technologies, particularly in cell and gene therapy and AI healthcare [1][2] - The center aims to create a full lifecycle ecosystem from research and development to industrialization, leveraging top global research resources and industry chain enterprises [2] Group 1 - The launch event featured the signing of agreements by 15 companies from the biotech and innovative drug development sectors, marking the first batch of enterprises to join the innovation center [1] - A dual-driven model of "industry + capital" was established through fund signing ceremonies, providing financial support for the long-term development of the innovation center [1] - The "Innovation Zhuang Coffee" brand was introduced to create an open resource platform, promoting a collaborative innovation ecosystem [1] Group 2 - The center is positioned as a strategic hub for the transformation of cutting-edge technologies in life sciences, contributing to the construction of Beijing's international science and technology innovation center [2] - Experts at the subsequent seminar discussed topics such as AI's role in enhancing public hospital development, reshaping pharmaceutical research and development, and driving virtual clinical trials through computational medicine [2] - The event attracted participation from representatives of universities, research institutions, industry associations, financial institutions, and enterprises, highlighting the collaborative nature of the initiative [2]

Group 1 - Yu Minhong, the founder of New Oriental, issued an apology letter to all employees after a previous internal letter caused controversy, explaining that his use of Antarctic references was not meant to boast but to share his experiences sincerely [4][5] - The apology letter emphasized the importance of mutual support between employees and the company, encouraging staff to maintain the company's image and resolve grievances internally [4][5] Group 2 - Zhang Junjie, the founder of Bawang Tea, confirmed his marriage and refuted rumors about his past, stating that he had never been married before meeting his wife and addressing the impact of false narratives on his family and business [7][8] - Zhang expressed the need to protect his family's reputation and urged the public not to spread rumors, highlighting the emotional toll these stories have taken on him and his loved ones [7][8] Group 3 - Intel's CEO Chen Lifeng denied rumors regarding a former TSMC executive allegedly taking confidential 2nm technology to Intel, asserting that such claims are baseless and emphasizing respect for intellectual property [9] - TSMC is reportedly conducting an internal investigation into whether the former executive misappropriated company secrets before his retirement [9] Group 4 - Meituan announced a plan to invest 10 billion yuan over the next five years to enhance rider protection, including the establishment of "rider apartments" in major cities [10] - The initiative aims to address the welfare needs of riders and expand the coverage of existing support programs for their families [10] Group 5 - The Ministry of Industry and Information Technology of China projected that the output value of civil aviation products will exceed 160 billion yuan in 2024, representing a year-on-year growth of 23.6% [23] - The ministry plans to promote the development of the civil aircraft industry and low-altitude equipment, focusing on technological innovation and integration with emerging industries [23]

Group 1 - China's daily crude oil imports have exceeded 10 million barrels, raising concerns and interpretations about its intentions, whether for opportunistic buying or long-term energy planning [1] - In the first half of 2023, China's crude oil imports reached 28.208 million tons, accounting for nearly 90% of the total increase in oil stock [1] - The crude oil import volume for 2025 is projected to reach 25.7 million tons, indicating growth compared to 2024, despite a year-on-year decline in early 2025 [1] Group 2 - China's procurement scale is significant enough to directly influence international oil prices, stabilizing them around $65 per barrel despite a general decline in oil prices globally [2] - Approximately 1 million tons of the imported crude oil is directly injected into storage facilities daily, with China's total storage capacity reaching 25.017 million cubic meters, of which about 60% is utilized [2] - The intention behind the increased oil procurement is not solely to stabilize prices but also to build strategic reserves in response to global uncertainties and geopolitical tensions [2][4] Group 3 - The push for increased oil reserves is driven by the Energy Law of the People's Republic of China, which mandates companies to fulfill storage obligations, and aims to hedge against fluctuations in the US dollar [4] - China's high dependence on foreign oil, reaching 77.63% in 2023, necessitates proactive measures to secure energy supplies amid potential disruptions [6] - The strategic accumulation of oil reserves is viewed as a national-level strategy to ensure energy security and reduce reliance on external sources, especially in light of ongoing geopolitical tensions [8]

身处新质生产力发展浪潮，如何成为一朵奋勇争先的浪花？11月21日下午，在天津举办的"青春华章 踏 浪新质潮"学习贯彻党的二十届四中全会精神网络主题宣传和互动引导活动中，来自高校的学生给出了 他们共同的回答——积极投身科技强国建设。 未来职业概念时装秀、青春分享会在第三篇章展开，三位来自高校科研、天开园创业等不同领域的青年 分享了将个人理想融入国家需要的成长故事。 在活动尾声，《有我》唱响全场，激励青年扎实走好脚下的每一步路，勇做时代的"弄潮儿"。 11月18日至21日上午，来自全国二十余家媒体的近百名媒体工作者走进天津市高新科技产业园区、高校 实验室以及科技创新企业，了解人工智能、新能源、生物科技、材料等领域的最新科技突破，触摸"天 津智造"的发展脉搏。（记者 马常艳） 从近代工业摇篮到现代智造重镇，天津正成为发展新质生产力的热土。活动第一篇章聚焦新质生产力发 展浪潮，生动阐释新质生产力的核心内涵与发展逻辑。中国新一代人工智能发展战略研究院执行院长、 信创海河实验室主任龚克与学生们一同"踏浪新质潮"；"两弹一星"功勋奖章获得者于敏之子于辛参与跨 时空对话，以亲身经历传递"干惊天动地事，做隐姓埋名人"的精神火种 ...

Core Viewpoint - Hunan Qiangu Biotechnology Co., Ltd. has been established with a registered capital of 5 million RMB, focusing on various biotechnology and agricultural services [1] Company Summary - The company is legally represented by Xu Zengcong [1] - The registered capital is 5 million RMB [1] - The business scope includes research and development of bio-based materials, organic fertilizers, and composite microbial fertilizers [1] - The company also engages in the sale of fertilizers, chemical fertilizers, and provides information technology consulting services [1] Industry Summary - The company operates in the biotechnology sector, specifically in the development and sale of bio-based materials and fertilizers [1] - It offers services related to soil pollution control and remediation, as well as ecological resource monitoring [1] - The company is involved in agricultural services, including the sale of agricultural seeds and technology services for pollution prevention [1]

Group 1 - Zhejiang Tianyuan Biotechnology Co., Ltd. is actively procuring clinical research equipment and has benefited from a tailored financing solution from Yongcheng Rural Commercial Bank, which has facilitated the development and production of new immunotherapeutic drugs [1] - The company, which specializes in human immune assessment and genetic testing, faced funding challenges typical of biotech firms, highlighting the importance of financial support in overcoming development bottlenecks [1] - In the Jiangbei District, a growing number of technology companies are accessing specialized financing solutions, including the "knowledge exchange for capital" product, which allows for the monetization of intellectual property [1] Group 2 - Jiangbei District has established a comprehensive financial support network aimed at addressing the core pain points of technology enterprises, such as high R&D costs and limited financing pathways [2] - The district has pioneered a "patent valuation + government credit enhancement" model to assist early-stage tech companies with financing difficulties, effectively converting patent technology into capital [2] - As of August this year, the Ningbo Zhengde SME Financing Guarantee Company has provided guarantees for 47 tech enterprises in the district, with a total guarantee amount of 135 million yuan [2] Group 3 - Jiangbei District is leveraging investment funds to enhance the local innovation atmosphere, focusing on key industrial chains and clusters [3] - The district has established the Ningbo Sensor Valley Venture Capital Fund, which has raised an initial fund of 70 million yuan and is targeting innovative leading enterprises and critical technology industries [3] - From January to August this year, the added value of high-tech industries in Jiangbei District grew by 8.5% year-on-year, ranking second in growth rate within Ningbo City [3]

Group 1 - The company Huawotian (Shanghai) Biotechnology Co., Ltd. has been established with a registered capital of 100,000 RMB [1] - The legal representative of the company is Sun Xueqing [1] - The business scope includes technology services, sales of fertilizers, pesticides, and agricultural machinery, among other activities [1] Group 2 - The company is involved in research and development of bio-organic fertilizers and composite microbial fertilizers [1] - It also provides services for pest control in crops and forestry [1] - The company operates under a business license and is allowed to conduct activities independently without prior approval for certain projects [1]

Core Viewpoint - The correction of the Q3 2025 report by Tianyu Biotechnology Co., Ltd. does not affect the company's overall financial performance or key financial metrics, ensuring the accuracy of financial data and disclosures [2][3][4]. Summary by Sections Correction Details - The correction involves adjustments to earnings per share, return on equity, and reclassification between long-term loans and current liabilities, but does not impact total assets, total liabilities, equity, revenue, or net profit [2][3]. - The company confirmed that the asset-liability ratio remains unchanged and that the correction will not affect the operating performance for the first three quarters of 2025 [2][3]. Review Process - The Audit Committee approved the correction on November 21, 2025, stating that it complies with relevant laws and regulations, and reflects the company's financial status more accurately [3]. - The Board of Directors also approved the correction, affirming that it aligns with the actual financial situation and relevant disclosure rules, with no impact on the asset and equity reporting, total liabilities, or cash flow statement [3]. Additional Notes - Other contents of the Q3 2025 report remain unchanged, and the corrected report will be disclosed on the Shanghai Stock Exchange's official website [4]. - The company expressed apologies for any inconvenience caused to investors and committed to enhancing the training of financial personnel and improving internal control mechanisms for financial data and disclosures [4].

Core Viewpoint - The Hang Seng Index Company announced adjustments to multiple indices, including the inclusion and exclusion of various stocks, which will take effect on December 8, 2023 [2][3]. Index Adjustments - The Hang Seng Technology Index will include Li Auto and exclude ASMPT, maintaining a total of 30 constituent stocks [2]. - The Hang Seng China Enterprises Index will add China Hongqiao, Innovent Biologics, and Yum China while removing New Energy, Haidilao, and New Oriental [2][3]. - The Hang Seng Composite Index will increase from 503 to 509 constituent stocks, adding companies such as FWD Group and Hesai Technology [2]. Market Performance - The Hong Kong stock market has experienced a continuous decline, with the Hang Seng Index dropping by 2.38% and the Hang Seng Technology Index by 3.21% on November 21 [4]. - Notable individual stock declines include JD Health down 8.6% and Xinyi Solar down over 7% [4]. Future Market Outlook - UBS expresses a positive outlook for the Hong Kong market, predicting a growth period supported by low interest rates and a weakening dollar, with a target for the MSCI Hong Kong Index set at 12,300 points by the end of 2026 [5][6]. - CITIC Securities anticipates continued inflow of southbound funds into Hong Kong stocks, particularly through ETF channels, benefiting from the complete AI industry chain and the listing of quality A-share companies in Hong Kong [6]. - The market is expected to experience a second round of valuation recovery and performance resurgence by 2026, with recommendations for investment in technology, healthcare, resources, consumer staples, and sectors benefiting from RMB appreciation [6]. Performance Metrics - In the first ten months of the year, the Hang Seng Index rose by 29.15% and the Hang Seng Technology Index by 32.23% [7]. - The potential return for the Hang Seng Index in a neutral scenario for the next year is estimated at 22.92%, with an optimistic scenario reaching 33.83% [7].